Rina Jiromaru

568 total citations
32 papers, 357 citations indexed

About

Rina Jiromaru is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Rina Jiromaru has authored 32 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Otorhinolaryngology, 19 papers in Oncology and 16 papers in Surgery. Recurrent topics in Rina Jiromaru's work include Head and Neck Cancer Studies (16 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Head and Neck Surgical Oncology (7 papers). Rina Jiromaru is often cited by papers focused on Head and Neck Cancer Studies (16 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Head and Neck Surgical Oncology (7 papers). Rina Jiromaru collaborates with scholars based in Japan. Rina Jiromaru's co-authors include Ryuji Yasumatsu, Takashi Nakagawa, Kazuki Hashimoto, Hidetaka Yamamoto, Muneyuki Masuda, Takahiro Hongo, Yoshinao Oda, Mioko Matsuo, Takashi Nakagawa and Kenichi Taguchi and has published in prestigious journals such as PLoS ONE, The American Journal of Surgical Pathology and Human Pathology.

In The Last Decade

Rina Jiromaru

31 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rina Jiromaru Japan 11 203 196 137 58 57 32 357
Naonobu Kunitake Japan 11 188 0.9× 159 0.8× 86 0.6× 30 0.5× 105 1.8× 38 361
Remco de Bree Netherlands 12 324 1.6× 258 1.3× 355 2.6× 34 0.6× 80 1.4× 20 547
A. Benlyazid France 9 175 0.9× 206 1.1× 101 0.7× 116 2.0× 129 2.3× 17 442
Trad Wadsworth United States 6 412 2.0× 311 1.6× 245 1.8× 113 1.9× 64 1.1× 7 561
Akihiro Terada Japan 15 393 1.9× 330 1.7× 279 2.0× 67 1.2× 83 1.5× 37 591
Sofía Hakim Spain 7 164 0.8× 181 0.9× 100 0.7× 20 0.3× 23 0.4× 9 310
Dan Ma China 8 208 1.0× 188 1.0× 23 0.2× 66 1.1× 36 0.6× 23 357
Anders Bilde Denmark 10 242 1.2× 203 1.0× 264 1.9× 47 0.8× 33 0.6× 18 388
Mária Gődény Hungary 10 125 0.6× 105 0.5× 94 0.7× 13 0.2× 60 1.1× 38 333
Peter Zbaeren Switzerland 7 250 1.2× 158 0.8× 152 1.1× 74 1.3× 41 0.7× 8 403

Countries citing papers authored by Rina Jiromaru

Since Specialization
Citations

This map shows the geographic impact of Rina Jiromaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rina Jiromaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rina Jiromaru more than expected).

Fields of papers citing papers by Rina Jiromaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rina Jiromaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rina Jiromaru. The network helps show where Rina Jiromaru may publish in the future.

Co-authorship network of co-authors of Rina Jiromaru

This figure shows the co-authorship network connecting the top 25 collaborators of Rina Jiromaru. A scholar is included among the top collaborators of Rina Jiromaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rina Jiromaru. Rina Jiromaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Hidetaka, Rina Jiromaru, Takahiro Hongo, et al.. (2024). Immunohistochemical p16 overexpression and Rb loss correlate with high‐risk human papillomavirus infection in endocervical adenocarcinomas. Histopathology. 84(7). 1178–1191. 3 indexed citations
2.
Yamamoto, Hidetaka, Misa Suzuki, Rina Jiromaru, et al.. (2024). The combination of p16 and Rb expression pattern is helpful to predict high-risk HPV infection and the primary site in lymph node metastases of squamous cell carcinoma. Pathology - Research and Practice. 263. 155642–155642.
3.
Jiromaru, Rina, Ryuji Yasumatsu, Mioko Matsuo, et al.. (2024). Clinical Analysis of Oral Squamous Cell Carcinoma: A Single-institution Experience. Cancer Diagnosis & Prognosis. 4(2). 105–110. 4 indexed citations
4.
Wakasaki, Takahiro, Ryuji Yasumatsu, Mika Tanabe, et al.. (2023). Lacrimal Sac Tumors: A Single-institution Experience, Including New Insights. In Vivo. 37(3). 1219–1225. 7 indexed citations
5.
Matsuo, Mioko, Kazuki Hashimoto, Ryunosuke Kogo, et al.. (2023). Utility of Precision Oncology Using Cancer Genomic Profiling for Head and Neck Malignancies. In Vivo. 37(5). 2147–2154. 1 indexed citations
6.
Matsuo, Mioko, Muneyuki Masuda, Moriyasu Yamauchi, et al.. (2023). Pembrolizumab MonotherapyVersusPembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma. In Vivo. 37(5). 2188–2196. 5 indexed citations
7.
Yamamoto, Hidetaka, Rina Jiromaru, Takahiro Hongo, et al.. (2023). HPV Infection in Squamous Cell Carcinoma of the Hypopharynx, Larynx, and Oropharynx With Multisite Involvement. The American Journal of Surgical Pathology. 47(9). 955–966. 3 indexed citations
8.
9.
Matsuo, Mioko, Ryuji Yasumatsu, Muneyuki Masuda, et al.. (2022). Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years. In Vivo. 36(4). 1881–1886. 8 indexed citations
10.
Jiromaru, Rina, Takashi Nakagawa, & Ryuji Yasumatsu. (2022). Advanced Nasopharyngeal Carcinoma: Current and Emerging Treatment Options. Cancer Management and Research. Volume 14. 2681–2689. 29 indexed citations
11.
Jiromaru, Rina, Ryuji Yasumatsu, Hidetaka Yamamoto, et al.. (2022). A clinical analysis of oropharyngeal squamous cell carcinoma: a single-institution’s experience. European Archives of Oto-Rhino-Laryngology. 279(7). 3717–3725. 2 indexed citations
12.
Yasumatsu, Ryuji, Kazuki Hashimoto, Takahiro Hongo, et al.. (2022). Real-world Experience With Pembrolizumab for Advanced-stage Head and Neck Cancer Patients: A Retrospective, Multicenter Study. Anticancer Research. 42(7). 3653–3664. 9 indexed citations
13.
Matsuo, Mioko, Kazuki Hashimoto, Takuro Isoda, et al.. (2022). Utility of FDG PET at the Initial Radioiodine Therapy in Differentiated Thyroid Cancer. Anticancer Research. 43(1). 183–190. 3 indexed citations
14.
15.
Matsuo, Mioko, Kazuki Hashimoto, Rina Jiromaru, & Takashi Nakagawa. (2022). Delayed pharyngocutaneous fistula caused by molecular targeted therapy: a case report. Journal of Medical Case Reports. 16(1). 383–383. 2 indexed citations
16.
Uchi, Ryutaro, Rina Jiromaru, Ryuji Yasumatsu, et al.. (2021). Genomic Sequencing of Cancer-related Genes in Sinonasal Squamous Cell Carcinoma and Coexisting Inverted Papilloma. Anticancer Research. 41(1). 71–79. 10 indexed citations
17.
Hongo, Takahiro, Hidetaka Yamamoto, Rina Jiromaru, et al.. (2020). Clinicopathologic Significance of EGFR Mutation and HPV Infection in Sinonasal Squamous Cell Carcinoma. The American Journal of Surgical Pathology. 45(1). 108–118. 31 indexed citations
18.
Yasumatsu, Ryuji, Mioko Matsuo, Takahiro Wakasaki, et al.. (2020). Clinical outcome in recurrent and/or metastatic head and neck cancer patients after discontinuation of nivolumab monotherapy due to immune-related adverse events. Acta Oto-Laryngologica. 140(12). 1043–1048. 8 indexed citations
19.
Yamamoto, Hidetaka, Kenichi Taguchi, Takahiro Hongo, et al.. (2020). Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma. Human Pathology. 109. 37–44. 9 indexed citations
20.
Sato, Masanobu, Hidetaka Yamamoto, Yui Hatanaka, et al.. (2018). Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland. Pathology - Research and Practice. 214(4). 586–592. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naonobu Kunitake Breakdown of academic impact, for papers by Remco de Bree Breakdown of academic impact, for papers by A. Benlyazid Breakdown of academic impact, for papers by Trad Wadsworth Breakdown of academic impact, for papers by Akihiro Terada Breakdown of academic impact, for papers by Sofía Hakim Breakdown of academic impact, for papers by Dan Ma Breakdown of academic impact, for papers by Anders Bilde Breakdown of academic impact, for papers by Mária Gődény Breakdown of academic impact, for papers by Peter Zbaeren
Rankless by CCL
2026